Serum cytokeratin 19 fragment in advanced lung cancer: could we eventually have a serum tumor marker?

por Bastawisy, Ahmed El, azzouny, Mahmoud El, Mohammed, Gamal, allah, Ahmad Awad, Behiry, Eman
Publicado 2014

BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions

por Sinha, Abhilasha, Paul, Bibbin T., Sullivan, Lisa M., Sims, Hillary, Bastawisy, Ahmed El, Yousef, Hend F., Zekri, Abdel-Rahman N., Bahnassy, Abeer A., ElShamy, Wael M.
Publicado 2016